Innovation drives everything

Dr. Falk Pharma – the experts in digestive and metabolic medicine

Newsroom
Organ_Keyvisual_Web_2400x900_1.mp4

Dr. Falk Pharma – Innovation drives everything

As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. For over 60 years. 
Our focus: To enable relief, well-being, more ease of movement and confidence in everyday situations for millions of people with inflammatory bowel disease as well as digestive and metabolic problems. With the best possible therapies.

Falk Foundation provides a platform for experts in the fields of gastroenterology and hepatology to meet and communicate with one another.

Innovation drives everything

Dr. Falk Pharma – the experts in digestive and metabolic medicine

Learn more

Knowledge drives everything

Falk Foundation – scientific dialogue to advance therapeutic progress

Learn more

Newsroom

What’s happening at Dr. Falk Pharma? Visit our Newsroom and follow us on social media for the latest news, press releases, clinical trial announcements, upcoming events and more from Dr. Falk Pharma.

Corporate

Elena in France

11.11.2024

3 cities and 6 encountes where she learned more about her grandpa and Falk

More

Corporate

Elena in the Netherlands

04.11.2024

... where she spoke to younger colleagues about Falk in Amsterdam

More

Corporate, Press release

Dr. Falk Pharma acquires Kynos Therapeutics

29.10.2024

...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio

More

Information for patients

broch_u82_psce
Brochure

Primary biliary cholangitis

Helping patients to understand their disease this brochure gives a comprehensive overview on primary biliary cholangitis.

Authors: Prof. T. Berg, Dr. T. Herta

Bu83e_4-1-22_Autoimmune_hepatitis
Brochure

Autoimmune hepatitis

By providing a comprehensive overview of autoimmune hepatitis, this brochure helps patients understand their disease.

Authors: Prof. Dr. H. Bantel, Prof. Dr. H. Wedemeyer

Brochure

Microscopic colitis

Up-to-date information for people suffering from microscopic colitis – a chronic inflammatory bowel disease.

Information for health care professionals

Screenshot_Session1
Foundation event

Gut Microbiome: Structure, Metabolic Activity And Clinical Application

The online event replacing the Falk Symposium in Sydney focused on microbial profiling and the challenges of microbiome manipulation. Watch all three sessions on demand.

Screenshot_PanelDiscussion
Foundation event

Panel Discussion: FMT – the Global Perspective

The panel discussion held during the digital ‘Gut Microbiome’ event explored the options for a consensual view on Fecal microbiota transplantation.

FALK FOUNDATION e.V.

The Falk Foundation organizes and supports scientific dialogue to advance therapeutic progress. We facilitate exchange of knowledge within the field of digestive and metabolic medicine through a wide range of platforms that are always comprehensive, up-to-date, and independent.

Common indications

Get informed on various diseases of the liver, the biliary tract, the intestinal tract as well as the esophagus with details on symptoms, course of the disease, diagnosis and treatment options.

All indications
magen-darm-trakt-illustration

Eosinophilic esophagitis is a rare disease of the esophagus involving chronic inflammation as well as difficulty and pain swallowing. The symptoms of the disease seriously affect quality of life. As the disease is progressive, long-term treatment is necessary.

More

Microscopic colitis consists of two conditions called lymphocytic colitis and collagenous colitis. It is an inflammatory bowel disease and primarily impacts the large intestine. Microscopic colitis can only be diagnosed by examining tissue samples under a microscope, colonoscopy findings are typically normal.

More

Primary biliary cholangitis (PBC) is a chronic autoimmune disease in which the small bile ducts are damaged by inflammation. Without adequate treatment, this inflammation may eventually spread to the tissue of the liver and even cause cirrhosis. PBC affects women much more often than men.

More